Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity
Ellen Van Damme · Figshare · 2021
This report describes the most relevant results of screening a drug repurposing library consisting of ~5500 FDA-approved drugs and clinical candidates that have passed phase I studies for activity against SARS-CoV-2.